J Otten

1.2k total citations · 1 hit paper
21 papers, 937 citations indexed

About

J Otten is a scholar working on Oncology, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, J Otten has authored 21 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Surgery and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in J Otten's work include Nausea and vomiting management (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Virus-based gene therapy research (2 papers). J Otten is often cited by papers focused on Nausea and vomiting management (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers) and Virus-based gene therapy research (2 papers). J Otten collaborates with scholars based in Belgium, France and United States. J Otten's co-authors include George S. Johnson, Ira Pastan, John P. Bader, Daniël De Wolf, Yves Benoît, J.E. Dumont, Bert Suys, Henri Verhaaren, Saı̈d Hachimi-Idrissi and C. Niemeyer and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J Otten

21 papers receiving 846 citations

Hit Papers

Cyclic AMP levels in fibroblasts: Relationship to growth ... 1971 2026 1989 2007 1971 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Otten Belgium 10 525 118 113 107 96 21 937
Z Lojda Czechia 17 344 0.7× 72 0.6× 274 2.4× 117 1.1× 94 1.0× 92 988
Arlette Maret France 18 746 1.4× 178 1.5× 138 1.2× 198 1.9× 88 0.9× 48 1.3k
Gania Kessler‐Icekson Israel 21 754 1.4× 105 0.9× 95 0.8× 91 0.9× 89 0.9× 63 1.3k
Núria Godessart Spain 21 412 0.8× 99 0.8× 228 2.0× 72 0.7× 50 0.5× 37 1.2k
Kazuhiko Matsuno Japan 16 306 0.6× 52 0.4× 69 0.6× 97 0.9× 113 1.2× 62 782
Osamu Sakai Japan 20 548 1.0× 126 1.1× 104 0.9× 78 0.7× 44 0.5× 45 1.1k
Lorin K. Johnson United States 17 574 1.1× 358 3.0× 106 0.9× 135 1.3× 189 2.0× 30 1.3k
Ivan Formentini Switzerland 12 535 1.0× 64 0.5× 87 0.8× 196 1.8× 172 1.8× 16 966
G S Duncan Canada 11 746 1.4× 69 0.6× 257 2.3× 90 0.8× 59 0.6× 14 1.4k
Peter Feick Germany 17 402 0.8× 55 0.5× 66 0.6× 109 1.0× 149 1.6× 31 898

Countries citing papers authored by J Otten

Since Specialization
Citations

This map shows the geographic impact of J Otten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Otten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Otten more than expected).

Fields of papers citing papers by J Otten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Otten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Otten. The network helps show where J Otten may publish in the future.

Co-authorship network of co-authors of J Otten

This figure shows the co-authorship network connecting the top 25 collaborators of J Otten. A scholar is included among the top collaborators of J Otten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Otten. J Otten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rößler, Jochen, Melchior Lauten, Carmen Martini, et al.. (2010). 3.P.08 LYMPHANGIOMATOSIS WITH SKELETAL INVOLVEMENT – AN ORPHAN DISEASE LONGING FOR THERAPY. 442–442. 1 indexed citations
3.
Wehl, Goetz, J Otten, Nelly Boehm, et al.. (2004). Response of Progressive Fibromatosis to Therapy with Liposomal Doxorubicin. Oncology Research and Treatment. 27(6). 552–556. 26 indexed citations
4.
Wolf, Daniël De, et al.. (1996). Dobutamine Stress Echocardiography in the Evaluation of Late Anthracycline Cardiotoxicity in Childhood Cancer Survivors. Pediatric Research. 39(3). 504–512. 53 indexed citations
5.
Benoît, Yves, Frank Hulstaert, C. Vermylen, et al.. (1995). Control of nausea and vomiting by Navoban® (tropisetron) in 131 children receiving cytotoxic chemotherapy. Anti-Cancer Drugs. 6. 9–14. 6 indexed citations
6.
Benoît, Yves, Frank Hulstaert, Christiane Vermylen, et al.. (1995). Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy. Medical and Pediatric Oncology. 25(6). 457–462. 9 indexed citations
7.
Wolf, Daniël De, Bert Suys, Dirk Matthys, et al.. (1994). Stress Echocardiography in the evaluation of late cardiac toxicity after moderate dose of anthracycline therapy in childhood. Ghent University Academic Bibliography (Ghent University). 1. 399–404. 5 indexed citations
8.
Hachimi-Idrissi, Saı̈d, Rik Schots, Daniël De Wolf, S.J.P. Van Belle, & J Otten. (1993). Reversible Cardiopathy After Accidental Overdose of Mitoxantrone. Pediatric Hematology and Oncology. 10(1). 35–40. 7 indexed citations
9.
Hachimi-Idrissi, Saı̈d, et al.. (1993). Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy. European Journal of Cancer. 29(6). 854–856. 16 indexed citations
10.
Vainsel, M, et al.. (1983). [Acute myeloblastosis in von Jaksch-Luzet syndrome].. PubMed. 40(6). 469–70. 3 indexed citations
11.
12.
Otten, J, et al.. (1978). Clinical trial of peptichemio in solid tumors of childhood.. PubMed. 62(7). 1015–9. 4 indexed citations
13.
Otten, J, John P. Bader, George S. Johnson, & Ira Pastan. (1972). A Mutation in a Rous Sarcoma Virus Gene That Controls Adenosine 3′,5′-Monophosphate Levels and Transformation. Journal of Biological Chemistry. 247(5). 1632–1633. 103 indexed citations
14.
Otten, J & J.E. Dumont. (1972). Glucose Metabolism in Normal Human Thyroid Tissue in vitro*. European Journal of Clinical Investigation. 2(4). 213–219. 18 indexed citations
15.
Otten, J, George S. Johnson, & Ira Pastan. (1972). Regulation of Cell Growth by Cyclic Adenosine 3′,5′-Monophosphate. Journal of Biological Chemistry. 247(21). 7082–7087. 271 indexed citations
16.
Otten, J, George S. Johnson, & Ira Pastan. (1971). Cyclic AMP levels in fibroblasts: Relationship to growth rate and contact inhibition of growth. Biochemical and Biophysical Research Communications. 44(5). 1192–1198. 374 indexed citations breakdown →
17.
Otten, J, Marc Jonckheer, & Jacques E. Dumont. (1971). Thyroid Albumin. II.In VitroSynthesis of a Thyroid Albumin by Normal Human Thyroid Tissue1. The Journal of Clinical Endocrinology & Metabolism. 32(1). 18–26. 13 indexed citations
18.
Otten, J, et al.. (1970). [Prolonged course of a syndrome associating alternative neutropenia, thrombopenia and hemolytic anemia, splenomegaly and multiple adenopathies].. PubMed. 27(4). 445–445. 2 indexed citations
19.
Otten, J, et al.. (1965). Studies on the effect of hypophysectomy and of partial hepatectomy on the aminoacid incorporating system from rat liver.. PubMed. 68(4). 251–64. 1 indexed citations
20.
Otten, J, et al.. (1963). [DETERMINATION OF ISOCITRATE DEHYDROGENASE, LACTIC DEHYDROGENASE AND GLUTAMIC-OXALACETIC TRANSAMINASE IN THE CEREBROSPINAL FLUID IN MULTIPLE SCLEROSIS].. PubMed. 63. 454–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026